KA-672 inhibits rat brain acetylcholinesterase in vitro but not in vivo

Neuroscience Letters

Volumn 263, Issue 2-3, 1999, Pages 193-196

  Hilgert, Michael ^a   Nöldner, Michael ^b   Chatterjee, Shyam S ^b   Klein, Jochen ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Acetylcholine; Acetylcholinesterase; KA 672; Microdialysis

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANSECULIN; DONEPEZIL; NOOTROPIC AGENT; RIVASTIGMINE; TACRINE;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID; CHOLINERGIC SYSTEM; CISTERNA MAGNA; COGNITION; CONTROLLED STUDY; DEMENTIA; DRUG DISTRIBUTION; DRUG EFFECT; DRUG PENETRATION; DRUG SOLUBILITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; HIPPOCAMPUS; LEARNING; LIPOPHILICITY; MEMORY; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANIMALS; BENZOPYRANS; BRAIN; CEREBRAL CORTEX; CHOLINESTERASE INHIBITORS; HIPPOCAMPUS; KINETICS; MICRODIALYSIS; PIPERAZINES; RATS;

EID: 0345435251     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00149-4     Document Type: Article

References (15)

1. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:1959;911-917.
2. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience. 19:1986;1-28.
3. Court J.A., Perry E.K. Dementia: the neurochemical basis of putative transmitter orientated therapy. Pharmac. Ther. 52:1991;423-443.
4. Cuadra G., Summers K., Giacobini E. Cholinesterase inhibitor effects on neurotransmitters in rat cortex in vivo. J. Pharmacol. Exp. Ther. 270:1994;277-284.
5. Damsma G., Westerink B.H.C., de Vries J.B., van den Berg C.J., Horn A.S. Measurement of acetylcholine release in freely moving rats by means of automated intracerebral dialysis. J. Neurochem. 48:1987;1523-1528.
6. Doctor B.P., Toker L., Roth E., Silman I. Microtiter assay for acetylcholinesterase. Anal. Biochem. 166:1987;399-403.
7. 4) acetylcholinesterase: structure, localization, and physiological regulation. J. Neurochem. 66:1996;1335-1346.
8. Fujii T., Yoshizawa M., Nakai K., Fujimoto K., Suzuki T., Kawashima K. Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Res. 761:1997;244-249.
9. Giacobini E. From molecular structure to Alzheimer therapy. Jpn. J. Pharmacol. 74:1997;225-241.
10. Kawashima K., Sato A., Yoshizawa M., Fujii T., Fujimoto K., Suzuki T. Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 350:1994;523-528.
11. Köppen A., Klein J., Erb C., Löffelholz K. Acetylcholine release and choline availability in rat hippocampus: effects of exogenous choline and nicotinamide. J. Pharmacol. Exp. Ther. 282:1997;1139-1145.
12. Nöldner M., Hauer H., Chatterjee S.S. Anseculine hydrochloride. Drugs Future. 21:1996;779-781.
13. Telting-Diaz M., Lunte C.E. Distribution of tacrine across the blood-brain barrier in awake, freely moving rats using in vivo microdialysis sampling. Pharm. Res. 10:1993;44-48.
14. Tucek S. Problems in the organization and control of acetylcholine synthesis in brain neurons. Prog. Biophys. Mol. Biol. 44:1984;1-46.
15. 1A component. Pharmacol. Biochem. Behav. 61:1998;703-707.